i-Target retweeted
Challenges and Opportunities for Pancreatic Cancer Immunotherapy dlvr.it/Rndj8P
Last seminar of 2020!
Great results colloquium from Magdalena Zaucha on the influence of genetic factors on immune response to Yellow Fever vaccination! Thank you, @magdalenazaucha!
2
i-Target retweeted
#CARTcell Therapie News vom #ASH20. Beim #ASHToday zusammengefasst von Prof. Peter Bader von der Uniklinik Frankfurt, Prof. Andreas Mackensen von der Uniklinik Erlangen, Prof. @MSubklewe vom @LMU_Uniklinikum und Prof. Simone Thomas von der @presse_ukr
👉 ash-today.de!
Last week the students enjoyed two days at the the i-Target fall workshop (virtually of course).
(Thread)
1
On the first day we had a lot of fun with our trainer Dr. Daniel Mertens at the very encouraging "Scientists Need More! Grant Writing and Getting Funded" Soft Skill workshop!
1
Weekly seminar
Very insightful talk given by our guest speaker, Dr. Carsten Marr from the Institute of Computational Biology, @HelmholtzMunich on artificial intelligence in computational hematopathology.
Thank you, @MarrCarsten!
1
Weekly seminar
Great results colloquium by @AnneMarieSenz on the impact of IDO1 depletion in adoptive T cell therapy!
Journal club:
nature.com/articles/s41586-0…
i-Target retweeted
Congrats to Saskia on her successful PhD defense! One of the pioneers of our antibody subgroup and a great person and scientist!
Weekly seminar
Results colloquium from Malte Ohlmeyer on modulation of T cell function by costimulatory and coinhibitory molecules during continuous application of T cell recruiting constructs for treatment of B cell malignancies.
Journal club:
thelancet.com/journals/lance…
Weekly seminar
Great results colloquium from @antoniosnews on generation of protective anti-viral immunity by the effective immunopriming of yellow fever vaccine virus!
Journal club:
nature.com/articles/s41467-0…
1
Thank you to the organizers and speakers for making the #itoc7 an amazing virtual conference!
@ITOCconference
i-Target retweeted
Check out the poster by our PhD candidate @AnneMarieSenz on how IDO1-deleted CAR T cells show improved therapeutic efficacy in murine pancreatic cancer models @ITOCconference @LMU_Uniklinikum @LMU_Muenchen @iTarget_ENB #Immunotherapy #CARTcells #IDO1 #PancreaticCancer
i-Target retweeted
Welcome to the 7th Immunotherapy of Cancer Virtual Conference! Join us for our welcome address itoc2020.h82.eu/
i-Target retweeted
Excited to hear about Synthetic agonistic receptor-activating BiTEs - a modular platform for the efficient targeting of acute myeloid leukemia from M.Res. Mohamed-Reda Benmebarek @BenmebarekMr on Saturday at @ITOCconference @LMU_Uniklinikum @LMU_Muenchen #Immunotherapy #leukemia
i-Target retweeted
Check out the poster from our medical student Carlotta Rambuscheck: Exploring tumor-intrinsic factors regulating the recruitment of myeloid-derived suppressor cells (MDSC) in pancreatic ductal adenocarcinoma.
Coming soon at @ITOCconference @LMU_Muenchen @LMU_Uniklinikum #ITOC7
i-Target retweeted
Excited to hear Dr. Daniel Böhmer talk on how Gemcitabine induces pro-apoptotic BH3 only proteins and sensitizes pancreatic ductal adenocarcinoma cells for RLH-triggered immunogenic cell death @ITOCconference @LMU_Uniklinikum #PancreaticCancer #Immunotherapy #ITOC7 #CancerTherapy
i-Target retweeted
Check out the poster from Dr. Bruno L. Cadilha @bcadilha : C-C chemokine receptor 8 tumor-directed recruitment enables CAR T cells to reject solid tumors. Coming soon @ITOCconference @LMU_Uniklinikum @LMU_Muenchen #Immunotherapy #CARTcells #ITOC7 #CancerTherapy
i-Target retweeted
Looking forward to Prof. Dr. Sebastian Kobolds talk on why adoptive T cells therapies fail for solid tumors. @ITOCconference on Saturday 3rd of October #Immunotherapy #cancerresearch #ITOC7
itoc-conference.eu/programme
i-Target retweeted
One Week To Go!
Join us for the ITOC7 Virtual Conference on Friday, October 2 and Saturday, October 3, 2020!
itoc-conference.eu








